Applied Therapeutics, Inc.
NASDAQ:APLT
0.3326 (USD) • At close April 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 79.398 | 49.898 | 16.657 | 53.888 | 57.466 | 18.85 | 18.748 | 3.277 |
| Short Term Investments
| 0 | 0 | 13.923 | 26.935 | 39.363 | 20.004 | 0 | 0 |
| Cash and Short Term Investments
| 79.398 | 49.898 | 30.58 | 80.823 | 96.829 | 38.854 | 18.748 | 3.277 |
| Net Receivables
| 0 | 0.285 | 0.275 | 0.525 | 0.505 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -0.275 | -0.525 | -0.505 | 0 | 0 | 0 |
| Other Current Assets
| 4.248 | 4.203 | 6.453 | 7.046 | 5.259 | 7.21 | 1.498 | 0.009 |
| Total Current Assets
| 83.646 | 54.386 | 37.308 | 88.394 | 102.593 | 46.155 | 20.246 | 3.286 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 2.792 | 0.447 | 1.055 | 1.498 | 1.913 | 2.234 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.253 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 |
| Total Non-Current Assets
| 3.045 | 0.447 | 1.055 | 1.498 | 1.913 | 2.234 | 0.3 | 0 |
| Total Assets
| 86.691 | 54.833 | 38.363 | 89.892 | 104.506 | 48.389 | 20.246 | 3.286 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 4.433 | 1.742 | 4.534 | 9.461 | 0.64 | 8.793 | 3.015 | 0.713 |
| Short Term Debt
| 0.406 | 0.739 | 0.954 | 0.884 | 0.812 | 0.712 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.667 | 0 | 15.572 | 19.636 | 4.686 | 0 | 0 |
| Other Current Liabilities
| 22.457 | 68.034 | 27.936 | 16.117 | 19.783 | 4.594 | 1.413 | 0.28 |
| Total Current Liabilities
| 27.296 | 71.182 | 33.424 | 26.462 | 21.235 | 14.099 | 4.428 | 0.993 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 2.389 | 0.038 | 0.828 | 1.782 | 2.664 | 3.366 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.759 | 0.05 | -0.891 | -1.332 | -1.683 | 0 | 6.254 |
| Total Non-Current Liabilities
| 2.389 | 0.797 | 0.878 | 0.891 | 1.332 | 1.683 | 0 | 6.254 |
| Total Liabilities
| 29.685 | 71.979 | 34.302 | 27.353 | 22.567 | 15.782 | 4.428 | 7.247 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 48.389 | 35.41 | 6.254 |
| Common Stock
| 0.035 | 0.008 | 0.005 | 0.003 | 0.002 | 0.001 | 0 | 0 |
| Retained Earnings
| -574.21 | -468.586 | -348.823 | -266.315 | -160.731 | -66.77 | -21.257 | -4.736 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0.051 | -0.107 | -0.112 | -0.002 | 0 | 0 |
| Other Total Stockholders Equity
| 631.181 | 451.432 | 352.828 | 328.958 | 242.78 | 99.378 | 1.665 | -5.479 |
| Total Shareholders Equity
| 57.006 | -17.146 | 4.061 | 62.539 | 81.939 | 32.607 | 15.818 | -3.961 |
| Total Equity
| 57.006 | -17.146 | 4.061 | 62.539 | 81.939 | 32.607 | 15.818 | -3.961 |
| Total Liabilities & Shareholders Equity
| 86.691 | 54.833 | 38.363 | 89.892 | 104.506 | 48.389 | 20.246 | 3.286 |